Registration
KING & SPALDING LLP for KANEKA PHARMA AMERICA, LLC
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID JOSEPH FARBER New | — |
| ALLISON F KASSIR New | Staff, Rep. McHale, OSD/DOD & House Armed Services Committee |
| PREEYA NORONHA PINTO New | Deputy GC, Principal Deputy GC, Acting GC, HHS |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| KANEKA CORPORATION | Japan | Japan | 51.0% | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| KANEKA AMERICAS HOLDING, INC. | Pasadena, TX, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.